Who Paid My Doc
Debra Wood
Clinical Pharmacology Randolph, NJ Medical Doctor
NPI 1740448737 CMS profile 1210216
7 Waterview Ln, Randolph, NJ 07869
General payments
$196,750
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Debra Wood of Randolph, NJ is reported in the CMS Open Payments database as having received $196,750 across 16 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $21,250 | 1 | |
| 2023 | General | $143,500 | 13 | |
| 2022 | General | $32,000 | 2 |
Beside peers
- Debra Wood
- New Jersey median
- Middle half of New Jersey
- National median
In program year 2025, general payments to Debra Wood were reported at $0. Among 31,834 New Jersey profiles paid that year, the median was $178 and the middle half received between $51 and $585.
Show as a table
| Year | Debra Wood | New Jersey median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $150 | $44–$542 | $163 |
| 2020 | $0 | $110 | $33–$349 | $114 |
| 2021 | $0 | $125 | $36–$419 | $132 |
| 2022 | $32,000 | $142 | $42–$480 | $149 |
| 2023 | $143,500 | $156 | $48–$510 | $160 |
| 2024 | $21,250 | $167 | $50–$562 | $164 |
| 2025 | $0 | $178 | $51–$585 | $169 |
Breakdown
Records
16 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Pharmacology in New Jersey
Related records
Clinical Pharmacology in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Pharmacology
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.